Bio-Rad Announces Receipt of New Ruling in Applied Biosystems Patent Infringement Dispute

HERCULES, Calif., Nov. 22  /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (AMEX: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced today that it is in receipt of a recommended ruling issued by the U.S. District Court for the District of Connecticut regarding the longstanding patent infringement dispute filed by Applera, on behalf of its Applied Biosystems group (ABI), against MJ Research, Inc. and the outstanding judgment against MJ Research. The Court has denied MJ Research's motion to enforce a settlement agreement established on August 29, 2005 among the parties. MJ Research and Bio-Rad plan to appeal this decision. In the interim, the company will continue to comply with the injunction issued by the Court on August 30, 2005.

This action is part of a patent infringement law suit relating to Polymerase Chain Reaction (PCR) and instruments (thermal cycler) for performing PCR. While Bio-Rad is a longtime licensee of certain intellectual property covered by Applera's patents, the company inherited responsibility for the 1998 patent infringement case brought against MJ Research as part of its August 2004 acquisition of MJ GeneWorks, Inc., the parent company of MJ Research.

Bio-Rad Laboratories, Inc. (http://www.bio-rad.com/) is a multinational manufacturer and distributor of life science research products and clinical diagnostics. It is based in Hercules, California, and serves thousands of research and industry customers worldwide through a network of more than 30 wholly owned subsidiary offices.

Various statements made within this press release may constitute "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. The forward-looking statements contained herein involve risks and uncertainties that could cause results to differ materially from the Company's expectations. 

DATASOURCE: Bio-Rad Laboratories, Inc.



CONTACT:  Christine Tsingos, Chief Financial Officer, or Ron Hutton,

Treasurer, both of Bio-Rad Laboratories, Inc., [phone], or





Web site:  http://www.bio-rad.com/ 

Copyright